0 CHECKOUT

PRODUCT FILTERS

REGION

999
749
738
697
696

COUNTRY

688
53
35
33
31

PRICE

256
657
1,060
2,223

PUBLISHED

215
608
1,209
2,223

PRODUCT TYPE

1,738
248
168
59
7
2
1

Cardiovascular Drugs

Although mortality rates for cardiovascular diseases declined consistently over the decade 1998-2008, heart disease and stroke are still the number one killer in the US. This fact that illustrates why cardiovascular drugs and therapeutics is such a key sector of the pharmaceutical industry.

The reports, books, and subscriptions listed under Research and Markets’ Cardiovascular category explore in-depth vital areas such as the latest clinical trials for treatments for a variety of afflictions such as hypertension, arrhythmia and stroke. Learn all the latest news about products and R&D of pharmaceutical companies, hospitals and universities, as well as the latest market trends in a wide selection of countries. Also featured is a selection of academic and clinical textbooks for those working at the coalface of cardiovascular pharmaceuticals. Show Less Read more

Hypertrophic Cardiomyopathy Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends, and Forecast, 2015 - 2023

This report on the hypertrophic cardiomyopathy therapeutics market studies the current and future prospects of the global market. Hypertrophic cardiomyopathy occurs if heart muscle cells enlarge and...

Published:  November 2015
Price:  From

Dyslipidemia Drugs Market: (By Drug Class - Statins, Bile Acid Resins, Fibric Acid and Omega-3 Fatty Acid Derivatives, Niacins, Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Dyslipidemia is a chronic metabolic syndrome, characterized by improper level of low density lipoprotein, high density lipoprotein, and triglycerides. This study on the dyslipidemia drugs market involves...

Published:  August 2015
Price:  From

Heparin Market - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022

Heparin Market (Unfractionated Heparin, Low Molecular Weight Heparin & Ultra Low Molecular Weight Heparin) - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022' This report...

Published:  June 2015
Price:  From

Cardiovascular Information System Market by System Type (CVIS, Cardiology PACS), Components (Software, Services), Mode of Operation (Web-based, Onsite), End User, Applications - Forecasts to 2020

Cardiovascular Information System Market by System Type (CVIS, Cardiology PACS), Components (Software, Services), Mode of Operation (Web-based, Onsite), End User, Applications (Catheterization, ECG,...

Published:  October 2015
Price:  From

Penicillin and Streptomycin Market - Forecast 2015-2020

Penicillin and Streptomycin are two prominent drugs used in the treatment of diseases caused due to bacteria. Penicillin refers to a group of antibiotics such as Pencilillium V, Penicillium G. Penicillin...

Published:  December 2015
Price:  From

Diabetes, Metabolic Syndrome and Cardiovascular Disease

There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a childhood disease...

Published:  January 2016
Price:  From

Global Heparin Market 2016-2020

About Heparin Heparin, a disaccharide anticoagulant or blood thinner, prevents the formation of blood clots. It is produced in the body by basophils and mast cells. It is stored within mast cells...

Published:  March 2016
Price:  From

Global Myocardial Infarction Drugs Market 2016-2020

About Myocardial Infarction Drugs Myocardial infarction, commonly known as heart attack, is the irreparable death of the heart tissue. It occurs when blood stops flowing to a part of the myocardium...

Published:  March 2016
Price:  From

Global Heparin Market 2015-2019

About Heparin Heparin is an anticoagulant or blood thinner produced by basophils and mast cells. Though it has no effect on already formed clots, it enables the body's natural clot lysis mechanisms...

Published:  June 2015
Price:  From

Global Hypertension Drugs Market 2016-2020

About Hypertension Drugs Hypertension, or high blood pressure (BP), develops when there is too much pressure against the inner walls of blood vessels. Depending on the pressure exerted, hypertension...

Published:  April 2016
Price:  From

Global Ischemic Heart Disease (IHD)Drugs Market 2015-2019

About IHD IHD is an abnormal condition of the human body marked by narrowing or blocking of the arteries that supply blood to the heart. It results from the buildup of plaque in the arteries. The condition...

Published:  July 2015
Price:  From

Heparin Industry in China - 2015

Currently there are 4 major productss in the global low molecular heparin preparation market: SNY’s enoxaparin sodium, Pfizer’s dalteparin sodium, GSK’s nadroparin calcium and LEO’s tinzaparin sodium....

Published:  August 2015
Price:  From

Global Congestive Heart Failure Drugs Market 2015-2019

About Congestive Heart Failure Drugs Congestive heart failure is a serious and complex condition in which the heart muscles are either damaged or have to work too hard. Although the heart beats, the...

Published:  January 2015
Price:  From

Global Statin Market 2015-2019

About Statin Statin is a structural analog of HMG-CoA enzyme and is effective in reducing LDL. It shows its pharmaceutical action by inhibiting the key enzyme involved in cholesterol synthesis, which...

Published:  July 2015
Price:  From

Congestive Heart Failure - Pipeline Analysis

"Congestive Heart Failure (CHF) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of CHF. The report covers all the drugs being developed in various...

Published:  June 2015
Price:  From

2016-2020 World Heparin Testing Market: Ambulatory Centers, Commercial Labs, Hospitals, Physician Offices, POC/Point-of-Care Locations--Competitive Landscape, Country Segment Forecasts, Innovative Technologies, Instrumentation Review

The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific...

Published:  March 2016
Price:  From

2016 Global Heparin Testing Market: Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, USA

The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific...

Published:  November 2015
Price:  From

2016-2020 Global Heparin Testing Market: Country Forecasts, Innovative Technologies, Competitive Strategies--USA, EU5, Japan

The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific...

Published:  March 2016
Price:  From

2015-2019 Global Heparin Market: US, Europe, Japan--Emerging Opportunities and Business Strategies--Competitive Landscape, Country Segment Forecasts, Innovative Technologies, Instrumentation Review

The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific...

Published:  July 2015
Price:  From

China Heparin Industry Report, 2015-2018

As the world's largest heparin API producer and exporter, China seizes about 80% share of the global heparin API market. After the explosive growth in 2008-2010, the stagnant international market and...

Published:  December 2015
Price:  From
Loading Indicator

Our Clients